tradingkey.logo
tradingkey.logo
Search

Nexalin Technology Advances Clinical Trial Of HALO Clarity Toward Q2 2026 Enrollment

ReutersApr 22, 2026 3:17 PM
facebooktwitterlinkedin

- Nexalin Technology Inc NXL.O:

  • NEXALIN TECHNOLOGY ADVANCES PIVOTAL CLINICAL TRIAL OF HALO™ CLARITY TOWARD Q2 2026 ENROLLMENT

  • NEXALIN TECHNOLOGY: PATIENT ENROLLMENT CURRENTLY EXPECTED TO BEGIN IN Q2 OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI